Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TNZ | Ann: TNZ NTA 02-09-2025 $1.99431 | 08:00 | 0 | 19 | |||
|
|||||||
TNZ | Ann: TNZ NTA 01-09-2025 $1.98470 | 02/09/25 | 0 | 39 | |||
|
|||||||
TNZ | Ann: TNZ NTA 29-08-2025 $1.96017 | 01/09/25 | 0 | 28 | |||
|
|||||||
TNZ | Ann: TNZ NTA 28-08-2025 $1.96034 | 29/08/25 | 0 | 83 | |||
|
|||||||
TNZ | Ann: TNZ NTA 27-08-2025 $1.95820 | 28/08/25 | 0 | 42 | |||
|
|||||||
TNZ | Ann: TNZ NTA 26-08-2025 $1.97789 | 27/08/25 | 0 | 47 | |||
|
|||||||
TNZ | Ann: TNZ NTA 25-08-2025 $2.00129 | 26/08/25 | 0 | 71 | |||
|
|||||||
TNZ | Ann: TNZ NTA 22-08-2025 $1.99714 | 25/08/25 | 0 | 46 | |||
|
See All Discussions